Treatment of advanced gallbladder cancer

Gallbladder cancer is a very serious malignant tumor disease. It has a relatively high mortality rate after it occurs. If it reaches the late stage of the disease, it will be more difficult to treat, which will increase the difficulty of treatment and bring more pain and suffering. So how should gallbladder cancer be treated in the late stage? Let's learn about it below.

Western medicine local treatment is not effective, and patients cannot tolerate surgery and chemotherapy. The combined use of biological treatment technology can effectively control the disease, relieve pain, and prolong life. It is recommended to use a biological combined treatment plan. How to treat gallbladder cancer in the late stage? Reasonable use of biological treatment technology may make it possible to achieve long-term survival with tumors.

The effect of combined cell immunotherapy after early cancer surgery is outstanding!

Cell immunotherapy is the latest tumor treatment technology that is superior to surgery, radiotherapy and chemotherapy. It is a treatment method that uses biotechnology to cultivate autologous immune cells that can kill tumors in a high-standard laboratory, and then infuse them into the body to directly kill cancer cells. Different from traditional treatment methods, cell immunotherapy mainly mobilizes the body's natural anti-cancer ability and restores the balance of the body's internal environment. Clinically, cell immunotherapy is often combined with postoperative treatment in the early stages of cancer.

Combined cell immunotherapy after cancer surgery can achieve: accurate elimination of residual tumor cells, prevention of recurrence and metastasis, and improvement of patients' quality of life and prolongation of life

1. Improve the success rate of surgery and prevent recurrence and metastasis.

2. Improve immunity and reduce the damage of surgery to immunity.

3. Reduce pain and improve patients’ quality of life.

How to treat gallbladder cancer in the late stage? Cell immunotherapy is the fourth tumor treatment mode after comprehensive treatment of surgery, radiotherapy and chemotherapy. It plays an increasingly important role in reducing postoperative recurrence and metastasis of tumor patients, improving patients' sensitivity and tolerance to radiotherapy and chemotherapy, and improving the quality of life and survival of tumor patients, especially cancer patients. In the 21st century, cell immunotherapy plays a leading role.

The most representative technology of cell immunotherapy is tumor cell immunotherapy. Tumor cell immunotherapy for cancer can improve its overall cure rate without causing any pain or toxic side effects to patients. It is currently the preferred technology for cancer treatment. Tumor cell immunotherapy won the Nobel Prize in Medicine in 2011 and is known as the most advanced technology for treating malignant tumors. Currently, many patients with malignant tumors have gained hope of life by relying on tumor cell immunotherapy. Since the application of tumor cell immunotherapy in the clinical treatment of malignant tumors, many cancer patients have achieved ideal treatment effects and quality of life, and the clinical treatment effect is very good.

Beating cancer depends on the choice of treatment

Clinically, cancer treatment still follows traditional surgery, radiotherapy and chemotherapy. In order to improve the treatment effect of cancer patients, many hospitals in my country have introduced tumor cell immunotherapy technology from abroad. Cell immunotherapy technology, with its advantages of no pain, no adverse reactions, and no toxic side effects, has become the first choice for cancer treatment and is trusted by more and more patients and their families.

On the basis of the original DC-CIK cell immunotherapy, multiple cells such as NK, CD3AK, γδT, etc. are introduced, and a flexible combination of multiple cells is used to provide patients with a more suitable multi-cell immunotherapy model. Multi-cell immunotherapy is to restore the damaged balance between the tumor and the body's defense by supplementing, inducing or stimulating the body's natural biological response regulators, resulting in tumor regression. It may have unique advantages in controlling tumor proliferation, preventing and delaying tumor recurrence and metastasis, and improving the quality of life of patients. It can also make up for the shortcomings of traditional treatments such as incompleteness, easy recurrence, and toxic side effects, and significantly improve the treatment effect of cancer patients.